Dubai is advancing as a next-generation financial hub, with DIFC driving competitiveness and outperforming traditional centres …
Hong Kong, Saudi Arabia set to launch US$1 billion fund, Paul Chan says
A ‘major Saudi development company’ will host a roadshow in Hong Kong next month to seek strategic partners, financial secretary says.
US sanctions Indian firms ‘helping’ Iran’s ballistic missile production
According to a statement from the US Department of State, the sanctions target individuals and firms in Iran, India, China, Hong Kong, the UAE, Turkey, Germany, and Ukraine. The US Treasury said these …
Wallem celebrates 100 years in Hong Kong with message of resilience and renewal
Hong Kong finance chief urges maritime sector to embrace change as Wallem marks milestone …
The Latest on Macau’s Shift Away from Gambling
The Portuguese administration legalized gambling as far back as 1847, seeking to restore severely depleted government coffers following Hong Kong’s emergence as a rival trading port. By the late …
Finance chief expects Hong Kong’s unemployment rate to stabilise or even decline
Financial Secretary Paul Chan expresses optimism amid economic momentum with the growth forecast for 2025 revised up to 3.2 per cent.
Hong Kong businessman charged with filing false SEC forms
A Hong Kong businessman has been indicted for allegedly filing false and deceptive investment adviser forms with the US SEC.
HONG KONG BUSINESSMAN INDICTED FOR ROLE IN FILING FALSE SEC INVESTMENT ADVISER FORMS ON BEHALF OF SHAM ENTITIES USED IN RAMP-AND-DUMP SCHEME
“The investing public relies on the accuracy and integrity of materials filed with the SEC,” said SEC Inspector General Kevin B. Muhlendorf. ” According to the indictment, Guanhua Su, 37, of Hong Kong …
HONG KONG BUSINESSMAN INDICTED FOR ROLE IN FILING FALSE SEC INVESTMENT ADVISER FORMS ON BEHALF OF SHAM ENTITIES USED IN RAMP-AND-DUMP SCHEME
“The investing public relies on the accuracy and integrity of materials filed with the SEC,” said SEC Inspector General Kevin B. Muhlendorf. ” According to the indictment, Guanhua Su, 37, of Hong Kong …
Chinese drug developer Biokin postpones Hong Kong listing, citing ‘market conditions’
Decision likely reflects ‘some pullback in risk appetite, with growth-stock share prices coming off their highs’, Morningstar analyst says.